Millendo Therapeutics, Inc. (NASDAQ:MLND) traded at $1.79 at last check on Monday, Jun 29, making a downturn move of -1.1% on its previous day’s price.

Looking at the stock we see that its previous close was $1.81 with the day’s price range being $1.7100 – 1.8400. In terms of its 52-week price range, MLND has a high of $12.807 and a low of $1.26. The company’s stock has gained about -32.71% over that past 30 days.

On the other hand, looking at the outlook for the MLND stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Based on estimates by 3 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Millendo Therapeutics, Inc. (MLND) stock as a Hold, while 2 rate it as a Buy. None analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.

Let’s briefly compare Millendo (MLND) stock to its peers. We find that today’s price change of -1.1% and -84.52% over the past 12 months for MLND competes that of Amgen Inc (AMGN), which has seen its stock price fall -0.55% in the latest trading session and is +25.66% over the last one year. Another of its peers Gilead Sciences Inc (GILD) has dropped -0.01% today, and is +10.36% up over the past year, while Vertex Pharmaceutic (VRTX) is also down -1.1% yet its price remains in the red at -84.52% over the same period. Amgen has a P/E ratio of 18.14 compared to Millendo’s 0 and Gilead’s 19.17. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 2.32% and 1.47%, respectively, in early deals.

According to data from Thomson Reuters, insiders hold 11.3% of the company’s shares while institutions hold 65.47%. The data shows that short shares as of June 14, 2020, stood at 755.06 Million at a short ratio of 0.66. This represents a 3.97% Short interest in Shares outstanding on June 14, 2020. Shares short rose in June from the previous month at 529.8 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -73.44% down in year-to-date price movement.